SAR445877
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer (NCT07500298) | M.D. Anderson Cancer Center | 2026-05-20 |
Track SAR445877 automatically
Every clearance here is in the API, with alerts when new ones post.